NIH Initiates Access Planning Efforts within Intramural Research Program

News & Announcements

NIH Initiates Access Planning Efforts within Intramural Research Program

Posted on January 10, 2025March 4, 2025

Share:

Image
Twitter
Image
LinkedIn
Image
Reddit

NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH outlining steps they intend to take to promote patient access to those licensed products. NIH will continue working with industry partners to develop additional resources and guidance in support of these efforts.

For more information see https://osp.od.nih.gov/policies/innovation-and-translation#tab1/

Questions may be sent to SciencePolicy@od.nih.gov

If you are not yet a subscriber to this listserv, please sign up here . Also, please consider following us on X @ NIH_OSP and LinkedIn.

Recent News & Announcements

NIH Releases Draft Policy on Sharing Summary Level Study Results with Clinical Research Participants for Public Comment

August 27, 2026

Research participants are at the heart of the NIH mission...

Read More

NIH Releases Draft Biosafety Policy for Research Involving Biohazards for Public Comment

August 19, 2026

Today, NIH has issued a request for public comment on its Draft Biosafety Policy...

Read More

White House Releases New U.S. Government Policy for Stopping High-Risk Life Sciences Research

July 28, 2026

Today, the Administration released the U.S. Government Policy for Stopping...

Read More